← FDA Drug Approvals (Drugs@FDA)

TOBRAMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2021-04-01

Drug application

FDA Application #

ANDA212848

Application type

Abbreviated New Drug Application (Generic)

Brand name

TOBRAMYCIN

Generic name

TOBRAMYCIN

Active ingredients

TOBRAMYCIN

Dosage form

SOLUTION

Route

INHALATION

Marketing status

Prescription

Sponsor

ALKEM LABS LTD

Manufacturer

Ascend Laboratories, LLC

First approval

2021-04-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown